Free PMHNP Practice Test: 40 Questions With Answers Explained

Answer: B. Gradually reduce citalopram to 20 mg daily and watch for relapse.

Citalopram's labeling sets 20 mg once daily as the maximum recommended dose for patients older than 60, because higher drug exposure at this age raises the risk of dose-dependent QTc prolongation. Remission doesn't change that ceiling. Bring the dose down gradually, explain why, and watch for relapse.

Why the other choices don't fit

• A. A QTc that stays above 500 ms is the point at which the label says to discontinue citalopram. It isn't permission to exceed the age-based maximum.
• C. Nothing here requires abandoning a drug that works, and stopping abruptly risks discontinuation symptoms. The label recommends gradual dose reduction.
• D. Adding another SSRI increases serotonergic risk and doesn't resolve the age-based citalopram dose limit.

Takeaway: For citalopram, age over 60, hepatic impairment, CYP2C19 poor-metabolizer status, and a CYP2C19 inhibitor each cap the dose at 20 mg per day.

Source: Celexa (citalopram) prescribing information, AbbVie, sections 2.3–2.4, 2.6, 5.2–5.3 and 7. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Advanced pharmacology (adverse effects) · NPCB 04 Evaluate · Older adult · PMHNP-01

Answer: C. Keep him with staff and arrange an urgent (STAT) emergency mental health evaluation.

NIMH's adult outpatient Brief Suicide Safety Assessment is clear: a yes to current suicidal thoughts means imminent risk. The patient needs an urgent or STAT mental health evaluation, can't be left alone, and the medical team should be notified. The matching disposition is an emergency psychiatric evaluation.

Why the other choices don't fit

• A. That's the NIMH disposition for patients who need further evaluation but are not at imminent risk. Current thoughts put him in the emergency category.
• B. NIMH says contracting for safety is not effective and may be dangerous or give a false sense of security.
• D. 988 belongs in every patient's resources, but it doesn't replace an emergency evaluation when risk is imminent.

Takeaway: "Right now" changes the disposition: don't leave the patient alone, and get a STAT evaluation.

Source: NIMH ASQ Toolkit: Adult Outpatient Brief Suicide Safety Assessment, PDF pp. 1–2; step 2, current suicidal thoughts; step 4, disposition. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Psychiatric emergency management (suicidal ideation) · NPCB 03 Plan · Adult · PMHNP-02

Answer: A. Bipolar I disorder

NIMH defines bipolar I disorder by manic episodes that last at least 7 days or by manic symptoms severe enough to need immediate hospital care. Depressive episodes usually occur as well. One documented manic episode establishes bipolar I, even when she walks in depressed.

Why the other choices don't fit

• B. That label ignores the documented manic episode.
• C. Bipolar II involves hypomanic episodes, which are less severe than mania, along with depressive episodes. A manic episode requiring hospitalization moves her to bipolar I.
• D. Cyclothymia involves hypomanic and depressive symptoms that don't meet full episode criteria. She has had a full manic episode.

Takeaway: One lifetime manic episode makes it bipolar I. Always take a lifetime mood history.

Source: NIMH: Bipolar Disorder, What is bipolar disorder?; bipolar I, bipolar II and cyclothymic disorder. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · DSM-5-TR diagnostic criteria · NPCB 02 Diagnose · Adult · PMHNP-03

Answer: D. HIPAA permits sharing necessary information with people who can prevent or lessen the threat.

HHS guidance explains that the Privacy Rule permits a provider, consistent with applicable law and ethical standards, to disclose necessary information to law enforcement, family members, or others reasonably able to prevent or lessen a serious and imminent threat, including the target (45 CFR 164.512(j)). Whether a warning is mandatory, not just permitted, comes from state law and court decisions such as Tarasoff, which vary by state.

Why the other choices don't fit

• A. The serious-and-imminent-threat permission exists precisely for this situation.
• B. No court order is required for a threat-prevention disclosure under 164.512(j).
• C. The permission extends to anyone reasonably able to prevent or lessen the threat, including law enforcement and the intended victim.

Takeaway: HIPAA permits the warning. State law decides whether you must.

Source: HHS OCR: HIPAA Privacy Rule and Sharing Information Related to Mental Health, PDF p. 7; serious/imminent threat and state duty-to-warn discussion. Checked September 22, 2026.

Study tags: ANCC V. Ethics, Legal Principles, and Cultural Care · Scope of confidentiality (duty to warn) · NPCB 04 Evaluate · Adult · PMHNP-04

Answer: A. Moderately severe depressive symptoms

In the 2001 PHQ-9 validation study, scores of 5, 10, 15, and 20 marked mild, moderate, moderately severe, and severe depression. A 17 falls in the 15-to-19 moderately severe band. The PHQ-9 measures severity and supports diagnosis. In the 580-patient primary-care interview subsample, a score of 10 or more had 88% sensitivity and 88% specificity for major depression against a structured interview. Those are study-specific estimates, not fixed performance in every population; the score still needs a clinician's evaluation.

Why the other choices don't fit

• B. Mild starts at 5. A 17 is two bands higher.
• C. Moderate is 10 to 14. A 17 is in the next band up.
• D. A questionnaire score isn't a confirmed diagnosis. It flags severity for clinical evaluation.

Takeaway: PHQ-9 cutpoints are 5, 10, 15, 20: mild, moderate, moderately severe, severe.

Source: Kroenke, Spitzer and Williams: The PHQ-9 (2001 validation study), Abstract; Tables 2–3; diagnostic validity. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Mental health screening tool selection and interpretation (PHQ-9) · NPCB 02 Diagnose · Adult · PMHNP-05

Answer: D. Neuroleptic malignant syndrome

The haloperidol label describes NMS as a potentially fatal syndrome with hyperpyrexia, muscle rigidity, altered mental status, and autonomic instability (irregular pulse or blood pressure, tachycardia, sweating), often with elevated CPK. That is this patient. Management starts with stopping the antipsychotic and providing intensive medical treatment and monitoring, so this is an emergency.

Why the other choices don't fit

• A. He takes no serotonergic drug, and his picture is rigidity with high CPK rather than twitching and brisk reflexes.
• B. Dystonia means sustained muscle contractions, usually in the first days of treatment. An isolated dystonic reaction does not best explain this full combination of high fever, generalized rigidity, confusion, autonomic instability, and elevated CPK.
• C. Tardive dyskinesia typically involves involuntary movements associated with cumulative exposure, although the label notes that it can occur after brief treatment. It does not best explain this acute hyperthermic, rigid, autonomically unstable presentation.

Takeaway: Antipsychotic plus fever, rigidity, mental status change, autonomic instability, and high CPK strongly suggests NMS and needs emergency assessment.

Sources: DailyMed: Haloperidol oral solution prescribing information, Warnings: Neuroleptic Malignant Syndrome and Tardive Dyskinesia; Adverse Reactions: Dystonia; Prozac (fluoxetine) prescribing information, Lilly, section 5.2, serotonin syndrome. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Advanced psychopharmacology (NMS) · NPCB 02 Diagnose · Adult · PMHNP-06

Answer: B. Say what you noticed, offer seating and door choices, and let her set the pace.

Pennsylvania DHS's summary of SAMHSA's trauma-informed approach sets out six key principles: safety; trustworthiness and transparency; peer support; collaboration and mutuality; empowerment, voice, and choice; and cultural, historical, and gender inclusion. Being open about what you noticed, giving her choices about the room, and letting her set the pace put safety, transparency, and choice into practice.

Why the other choices don't fit

• A. Pressing on ignores her psychological safety and her voice in the visit.
• C. Labeling a trauma response as resistance undermines trust and collaboration.
• D. An unexplained handoff removes her choice and damages trust. Ask what would help her feel safe before deciding together whether a referral is needed.

Takeaway: Trauma-informed care in practice means safety, transparency, and choice, starting with where everyone sits.

Source: Pennsylvania DHS: Trauma-Informed Organizations, Six key principles; Safety; Trustworthiness and Transparency; Empowerment, Voice, and Choice. Checked September 22, 2026.

Study tags: ANCC IV. Psychotherapy and Related Theories · Therapeutic alliance development and management (trauma-informed approach) · NPCB 01 Assess · Adult · PMHNP-07

Answer: C. Cognitive processing therapy (CPT)

The 2023 VA/DoD guideline strongly recommends individual, manualized, trauma-focused psychotherapies (cognitive processing therapy, prolonged exposure, or EMDR) and recommends these psychotherapies over medication when both are available. His preference and access make CPT the best fit.

Why the other choices don't fit

• A. The guideline recommends against benzodiazepines for PTSD.
• B. Sertraline is a recommended medication, but the guideline prefers the recommended psychotherapies when both are available, and he wants therapy.
• D. The guideline recommends against cannabis and cannabis-derived products for PTSD.

Takeaway: PTSD first line: trauma-focused psychotherapy (CPT, PE, or EMDR). The VA/DoD guideline recommends against benzodiazepines and cannabis for treating PTSD.

Sources: VA National Center for PTSD: Overview of Psychotherapy for PTSD, Recommended individual trauma-focused therapies; VA National Center for PTSD: Clinician's Guide to Medications for PTSD, Medication monotherapy table; Benzodiazepines; Cannabis. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · Evidence-based practice (psychotherapy selection) · NPCB 03 Plan · Older adult · PMHNP-08

Answer: D. Moderate withdrawal

The COWS bands are 5 to 12 mild, 13 to 24 moderate, 25 to 36 moderately severe, and above 36 severe. A score of 14 falls in the moderate band. The score describes withdrawal severity; it is not, by itself, a prescribing instruction or a complete assessment of when to start buprenorphine.

Why the other choices don't fit

• A. Mild withdrawal is 5 to 12. A 14 is in the next band.
• B. A 14 is not below the mild range; it is moderate withdrawal.
• C. Severe starts above 36. A 14 is moderate.

Takeaway: COWS bands are 5–12, 13–24, 25–36, and above 36. A score of 14 means moderate withdrawal.

Source: PCSS: Clinical Opiate Withdrawal Scale, One-page form, scoring-band footer. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Substance use screening tool selection and interpretation (COWS) · NPCB 02 Diagnose · Adult · PMHNP-09

Answer: B. Each order is limited to 2 hours at his age, with a face-to-face evaluation within 1 hour.

The federal patients' rights rule limits orders for violent or self-destructive behavior to 2 hours for patients 9 to 17, with renewals allowed under those limits for up to 24 hours. After 24 hours, an authorized physician or other licensed practitioner must see and assess the patient before writing a new order. It requires a face-to-face evaluation within 1 hour of starting the restraint, and it requires restraint to end at the earliest possible time regardless of how long the order allows.

Why the other choices don't fit

• A. The rule prohibits standing or as-needed (PRN) orders.
• C. Four hours is the limit for adults 18 and older. For ages 9 to 17, it's 2 hours.
• D. Restraint must end at the earliest possible time, whatever time remains on the order.

Takeaway: For violent or self-destructive restraint in a covered hospital: order limits are 4, 2, and 1 hours by age (18 and up, 9 to 17, under 9), unless state law is stricter. Face-to-face within 1 hour. Never PRN.

Source: 42 CFR 482.13: Hospital patients' rights, paragraphs (e)(6), (e)(8)–(9) and (e)(12). Checked September 22, 2026.

Study tags: ANCC V. Ethics, Legal Principles, and Cultural Care · Ethics in clinical decision making (least restrictive care) · NPCB 04 Evaluate · Adolescent · PMHNP-10

Answer: C. HLA-B\*1502 genotyping

Carbamazepine's boxed warning links Stevens-Johnson syndrome and toxic epidermal necrolysis to HLA-B\*1502, an inherited allele found almost exclusively in people with ancestry across broad areas of Asia. Patients from at-risk populations should be screened before starting, and those who test positive shouldn't receive carbamazepine unless the benefit clearly outweighs the risk.

Why the other choices don't fit

• A. CYP2D6 matters for other drugs (fluoxetine, for example, inhibits it), but it isn't the test in carbamazepine's boxed warning.
• B. CYP2C19 poor-metabolizer status limits citalopram dosing. It isn't the carbamazepine safety screen.
• D. A pretreatment serum drug level does not identify HLA-B\*1502 or replace the genetic screen in the boxed warning.

Takeaway: HLA-B\*1502 before carbamazepine in patients with at-risk ancestry. It's a textbook gene-drug interaction.

Sources: DailyMed: Carbamazepine extended-release capsules, ANI, Boxed Warning: Serious Dermatologic Reactions and HLA-B\*1502 Allele; Prozac (fluoxetine) prescribing information, Lilly, section 7.7, CYP2D6 inhibition; Celexa (citalopram) prescribing information, AbbVie, section 2.3, CYP2C19 poor metabolizers. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Psychopharmacogenomics (gene-drug interactions) · NPCB 01 Assess · Adult · PMHNP-11

Answer: A. "What do you think might be some benefits of cutting back, for you and your kids?"

NIAAA's brief intervention model builds motivation with open-ended questions and by listening for the patient's own reasons to change. She just offered one. Inviting her to say more helps her hear her own argument for change, and NIAAA notes that this "change talk" is associated with better alcohol outcomes.

Why the other choices don't fit

• B. Advice has a place in brief intervention, but this skips past the reason she just gave you.
• C. Referral can come later, especially for alcohol use disorder, but it's premature before her motivation is explored.
• D. A closed demand for commitment works against the autonomy NIAAA asks clinicians to support.

Takeaway: When a patient hands you a reason to change, ask an open question that invites more.

Source: NIAAA: Conduct a Brief Intervention—Build Motivation and a Plan for Change, Seven-step model, especially steps 2–5. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Clinical interviewing (motivational interviewing) · NPCB 01 Assess · Adult · PMHNP-12

Answer: C. Arrange prompt clinical evaluation, including an absolute neutrophil count (ANC), and act on the findings per the label.

FDA removed the Clozapine REMS effective June 13, 2025, so prescribers and pharmacies no longer enroll or report ANC results to it. The risk of severe neutropenia did not go away. It is greatest in the first several months of treatment, and FDA says prescribers should keep monitoring ANC according to the prescribing information. FDA lists fever and throat infection among symptoms patients should report, and at week 10 he's squarely in the higher-risk window.

Why the other choices don't fit

• A. The REMS was an administrative program. ANC monitoring continues under the prescribing information.
• B. That reporting requirement ended when the REMS was removed.
• D. Fever and sore throat on clozapine need prompt evaluation for neutropenia, not a wait.

Takeaway: The Clozapine REMS is gone, but ANC monitoring and prompt checks for infection symptoms are not.

Source: FDA: Removal of the Clozapine REMS, What is FDA announcing?; What should health care professionals/patients do?. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · Psychopharmacotherapeutic management (monitoring) · NPCB 04 Evaluate · Adult · PMHNP-13

Answer: A. Exposure and response prevention (ERP)

She is exposing herself to a feared trigger (the doorknob) while preventing the usual compulsive response (washing). That is exposure and response prevention, an evidence-based psychotherapy for OCD.

Why the other choices don't fit

• B. Relaxation doesn't involve facing the trigger or blocking the ritual.
• C. DBT targets emotion regulation, distress tolerance, and relationships. It isn't the standard OCD treatment described here.
• D. That approach is the first-line treatment for ADHD in young children, not a technique the child practices for OCD.

Takeaway: ERP for OCD means approach a safe trigger with the therapist's guidance and resist the ritual.

Sources: NIMH: Obsessive-Compulsive Disorder, Treatment: Psychotherapy; Exposure and response prevention; NIMH: Borderline Personality Disorder, How is borderline personality disorder treated?; Psychotherapy; DBT; CDC: Treatment of ADHD, Treatment recommendations; By Age Group; Behavior therapy. Checked September 22, 2026.

Study tags: ANCC IV. Psychotherapy and Related Theories · Psychotherapy principles (behavioral) · NPCB 03 Plan · Pre-adolescent · PMHNP-14

Answer: D. Offer a qualified interpreter, in person or remotely, at no cost to the family.

When interpretation is needed for meaningful access, Section 1557's language-access rule requires a covered entity to offer a qualified interpreter, free of charge. It bars relying on a minor child to interpret except briefly in an emergency involving an imminent threat while a qualified interpreter is found. It also bars relying on staff who are neither qualified interpreters nor qualified bilingual or multilingual staff. Remote video or audio interpreting is allowed when it meets the rule's quality requirements.

Why the other choices don't fit

• A. Consent doesn't lift the restriction on relying on a minor child in a nonemergency.
• B. The rule bars relying on staff who aren't qualified interpreters or qualified bilingual staff.
• C. That doesn't provide the meaningful language access the rule requires.

Takeaway: Use a qualified interpreter, free to the patient. Don't use children or untrained staff.

Source: 45 CFR 92.201: Meaningful access for individuals with limited English proficiency, (a)–(c); (e)(3)–(4); (f)–(g). Checked September 22, 2026.

Study tags: ANCC V. Ethics, Legal Principles, and Cultural Care · Equity, diversity, and inclusion (specific populations) · NPCB 01 Assess · Pre-adolescent · PMHNP-15

Answer: B. Hold lithium and arrange urgent evaluation with a lithium level and renal function.

This is a textbook setup for lithium toxicity. Lithium labeling lists volume depletion, recent illness, and drugs that affect the kidneys as risk factors, and NSAIDs such as ibuprofen reduce renal blood flow, which lowers lithium clearance and raises the serum level. Ataxia and slurred speech are moderate toxicity signs, and confusion is a severe one. Older adults can show toxicity at levels other patients tolerate. When toxicity signs appear, the label says to reduce or stop lithium, and severe cases may need hemodialysis.

Why the other choices don't fit

• A. A fine hand tremor is a common effect. A coarse tremor that arrives with ataxia, slurred speech, and confusion is not.
• C. Volume depletion increases lithium-toxicity risk. Raising the dose moves in exactly the wrong direction.
• D. Benztropine does not treat lithium toxicity. Continuing lithium without urgently evaluating this symptom cluster leaves the cause unaddressed.

Takeaway: Dehydration plus an NSAID plus older age is a lithium-toxicity setup. Coarse tremor, ataxia, and confusion mean stop and check.

Source: DailyMed: Lithium carbonate capsules, Glenmark, sections 2.3, 5.1, 7.1 and 10. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Advanced physical assessment · NPCB 04 Evaluate · Older adult · PMHNP-16

Answer: A. Gather reports from parents and other informants and assess impairment across settings.

The current CDC diagnostic guidance, summarizing the AAP approach, call for a diagnostic evaluation using DSM criteria that assesses how much the child is impaired and how pervasive that impairment is across multiple settings. That evaluation draws on multiple informants, such as parents, teachers, and other adults in the child's life, and the child when appropriate. One teacher's scale is a start, not a diagnosis.

Why the other choices don't fit

• B. A single setting and a single informant don't meet the evaluation standard.
• C. A single quiet visit can't capture behavior across the settings the evaluation requires.
• D. A treatment trial isn't one of the recommended diagnostic steps. The evaluation rests on criteria and multiple informants.

Takeaway: ADHD evaluation means multiple informants and multiple settings.

Source: CDC: Diagnosing ADHD, How ADHD is diagnosed; DSM-5 criteria; reports across settings. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Mental health screening tool selection and interpretation · NPCB 01 Assess · Pre-adolescent · PMHNP-17

Answer: C. Delirium superimposed on dementia

MedlinePlus describes delirium as coming on fast, over hours to a few days, with trouble staying focused and symptoms that come and go through the day. It often has a medical trigger such as infection, medicines, or low sodium. Dementia, by contrast, starts with minor symptoms that worsen over time. A one-day change in attention and alertness during an infection strongly suggests delirium superimposed on dementia, and it needs prompt medical evaluation.

Why the other choices don't fit

• A. Dementia progression is gradual. This change happened in a day.
• B. The important change is from her own baseline: new, fluctuating inattention and alertness during an acute illness. Do not dismiss that as ordinary dementia variation.
• D. Nothing here describes psychosis, and a sudden fluctuating attention problem during an infection points to delirium.

Takeaway: Sudden onset, fluctuating attention, and a medical trigger suggest delirium, even in someone with dementia.

Source: MedlinePlus: Delirium, What is delirium?; symptoms, causes, risk factors and diagnosis. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · Diagnosis (including differentials) · NPCB 02 Diagnose · Older adult · PMHNP-18

Answer: B. Listen to his concerns, but don't disclose her information.

HHS guidance says that when an adult patient with capacity objects to sharing information with family, the provider must respect her wishes in this family-involvement situation. A serious and imminent threat can permit disclosure to a family member able to lessen it, but that exception is absent here. HHS even gives the example of a nurse who may not discuss a patient's condition with her brother after she said she didn't want family to know. HIPAA doesn't stop you from listening to family concerns and factoring them into care.

Why the other choices don't fit

• A. Being next of kin doesn't override an objection from a patient who has capacity.
• C. A medication list is still her health information, and she objected.
• D. Age doesn't change her privacy rights or her capacity.

Takeaway: For this family-information request, the patient's informed objection stands: you can listen without disclosing her information.

Source: HHS OCR: HIPAA Privacy Rule and Sharing Information Related to Mental Health, PDF pp. 2–3; adult objection to family disclosure and receiving information from family. Checked September 22, 2026.

Study tags: ANCC V. Ethics, Legal Principles, and Cultural Care · Scope of confidentiality (release of information) · NPCB 04 Evaluate · Older adult · PMHNP-19

Answer: D. Serotonin syndrome

Tramadol is one of the serotonergic drugs the fluoxetine label names as raising the risk of serotonin syndrome. His picture matches the label's three clusters: mental status change (agitation), autonomic instability (sweating, fever), and neuromuscular signs (tremor, myoclonus, hyperreflexia), plus diarrhea. The label directs stopping fluoxetine and the other serotonergic drug and starting supportive treatment, so he needs urgent evaluation.

Why the other choices don't fit

• A. NMS is linked to antipsychotics, and he takes none. Myoclonus and brisk reflexes right after a new serotonergic drug point elsewhere.
• B. Discontinuation symptoms follow stopping or reducing an antidepressant. He has done neither.
• C. The label describes hyponatremia with headache, confusion, weakness, and unsteadiness. It doesn't explain fever, sweating, and myoclonus appearing right after a new serotonergic drug.

Takeaway: New serotonergic drug plus autonomic signs plus neuromuscular hyperactivity points to serotonin syndrome.

Sources: Prozac (fluoxetine) prescribing information, Lilly, sections 5.2, 5.9 and 5.15; DailyMed: Haloperidol oral solution prescribing information, Warnings: Tardive Dyskinesia; Neuroleptic Malignant Syndrome; Adverse Reactions: Dystonia. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Advanced psychopharmacology (pharmacodynamics) · NPCB 02 Diagnose · Adult · PMHNP-20

Answer: D. Complete a brief suicide safety assessment, then choose a disposition.

NIMH's Brief Suicide Safety Assessment is designed for this moment. It follows a positive screen and covers how often the thoughts occur, any plan and access to means, intent, past suicidal behavior (the strongest risk factor for future attempts), symptoms, and supports. Only then is a disposition chosen.

Why the other choices don't fit

• A. Denying current thoughts doesn't complete the assessment. NIMH notes that even a "no" to needing help doesn't mean a patient is safe.
• B. Emergency evaluation is the NIMH disposition for imminent risk, meaning current suicidal thoughts. Other positive screens lead to other dispositions after assessment.
• C. A suicide-risk screen isn't a diagnostic instrument for depression.

Takeaway: A positive screen starts the assessment. It doesn't finish it.

Source: NIMH ASQ Toolkit: Adult Outpatient Brief Suicide Safety Assessment, PDF pp. 1–2; initial instructions, step 2 assessment and step 4 disposition. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Risk assessment · NPCB 01 Assess · Adult · PMHNP-21

Answer: A. Coordinated specialty care from a team that includes family and school support

NIMH's RAISE research found that team-based coordinated specialty care produced better clinical and functional outcomes than typical community care, and worked best when started soon after psychotic symptoms began. The team offers recovery-oriented psychotherapy, medication management, family education and support, case management, and help with work or school. That lines up with his goals.

Why the other choices don't fit

• B. Medication management is one piece of coordinated specialty care, not the whole model.
• C. Educational support helps, but without clinical follow-up it leaves out most of what worked in RAISE.
• D. RAISE found treatment works best soon after symptoms begin.

Takeaway: First-episode psychosis: coordinated specialty care, started early.

Source: NIMH: RAISE-ing the Standard of Care for Schizophrenia, Coordinated specialty care; Results of RAISE research. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · Evidence-based practice · NPCB 03 Plan · Adolescent · PMHNP-22

Answer: C. Dialectical behavior therapy (DBT)

NIMH describes DBT as a therapy developed specifically for people with borderline personality disorder. It teaches mindfulness and skills to manage intense emotions, reduce self-destructive behavior, and improve relationships. Those treatment targets fit this presentation.

Why the other choices don't fit

• A. ERP treats OCD by approaching feared triggers while resisting compulsions. It is not the BPD-focused skills treatment described here.
• B. CPT is a trauma-focused therapy recommended for PTSD.
• D. That's a first-line treatment for ADHD in young children.

Takeaway: Borderline personality disorder with self-injury: DBT.

Sources: NIMH: Borderline Personality Disorder, How is borderline personality disorder treated?; Psychotherapy; DBT; NIMH: Obsessive-Compulsive Disorder, Treatment: Psychotherapy; Exposure and response prevention; VA National Center for PTSD: Overview of Psychotherapy for PTSD, Recommended individual trauma-focused therapies; CDC: Treatment of ADHD, Treatment recommendations; By Age Group; Behavior therapy. Checked September 22, 2026.

Study tags: ANCC IV. Psychotherapy and Related Theories · Psychotherapy principles · NPCB 03 Plan · Adult · PMHNP-23

Answer: B. Ask how his beliefs shape his preferences and plan with him from options he accepts.

The National CLAS Standards' principal standard calls for care that is effective, understandable, and respectful and that responds to a person's cultural health beliefs and practices. The way to learn this man's beliefs is to ask him, and then build the plan with him.

Why the other choices don't fit

• A. That dismisses his health beliefs instead of responding to them.
• C. Background reading can help, but it can't tell you what this person believes or wants.
• D. He's an adult who can speak for himself, and the preferences that matter are his.

Takeaway: Culturally responsive care starts with asking this patient, not a stereotype or a relative.

Source: HHS Office of Minority Health: National CLAS Standards, Principal Standard. Checked September 22, 2026.

Study tags: ANCC V. Ethics, Legal Principles, and Cultural Care · Cultural and spiritual competence · NPCB 01 Assess · Adult · PMHNP-24

Answer: B. His prefrontal cortex is still maturing, and peers weigh heavily at this age.

NIMH explains that the brain stops growing in size by early adolescence but keeps developing into the mid-to-late 20s. The prefrontal cortex, which handles planning, prioritizing, and decision-making, is one of the last areas to mature. Along with a stronger focus on peer relationships, that ongoing development may lead teens to take more risks. NIMH also notes those risks can be positive, like joining a new club.

Why the other choices don't fit

• A. Size and maturity aren't the same. Development continues well after growth stops.
• C. "Only" is the problem. The NIMH explanation centers on brain development and social context.
• D. Some mental illnesses do emerge in adolescence, but risk-taking with peers isn't itself a sign of one.

Takeaway: The prefrontal cortex is one of the last areas to mature; development continues into the mid-to-late 20s. Peer relationships also influence adolescent choices.

Source: NIMH: The Teen Brain—7 Things to Know, Items 1–2. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Neurodevelopment · NPCB 01 Assess · Adolescent · PMHNP-25

Answer: D. A personal and family history screen for bipolar disorder

Citalopram's label says to screen for any personal or family history of bipolar disorder, mania, or hypomania before starting citalopram or any other antidepressant. Treating a depressive episode with an antidepressant alone in someone with bipolar disorder can precipitate a mixed or manic episode. At 66, remember the other citalopram rule too: his maximum dose is 20 mg per day.

Why the other choices don't fit

• A. The labeling doesn't call for an EEG before an antidepressant.
• B. The label does not call for a pretreatment citalopram concentration; it specifically calls for bipolar-disorder screening.
• C. That isn't part of antidepressant pre-treatment screening.

Takeaway: Before any antidepressant, ask about personal and family history of bipolar disorder, mania, or hypomania.

Sources: Celexa (citalopram) prescribing information, AbbVie, sections 2.2–2.3 and 5.5; Prozac (fluoxetine) prescribing information, Lilly, section 5.4. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Mental health screening tool selection and interpretation · NPCB 01 Assess · Older adult · PMHNP-26

Answer: A. Kidney and thyroid function, electrolytes, vitals, other medications, pregnancy status

The lithium label's pre-treatment screening section lists exactly these: renal function, vital signs, serum electrolytes, and thyroid function, plus a review of concurrent medications and, for women of childbearing potential, pregnancy status and potential. The cited lithium carbonate capsule label calls for the first serum lithium concentration after 3 days of treatment, drawn 12 hours after the last dose.

Why the other choices don't fit

• B. Lithium is cleared by the kidneys and affects the thyroid, which is why those appear on the list. Liver enzymes and lipase aren't the screening set.
• C. A pretreatment lithium concentration does not replace the required baseline evaluation. The cited capsule label schedules the initial treatment-monitoring level after 3 days, 12 hours after the last dose.
• D. That's the carbamazepine screen, not a lithium one.

Takeaway: Before lithium: kidneys, thyroid, electrolytes, vitals, current medications, and pregnancy status.

Sources: DailyMed: Lithium carbonate capsules, Glenmark, sections 2.1–2.2; pretreatment screening and initial concentration; DailyMed: Carbamazepine extended-release capsules, ANI, Boxed Warning: Serious Dermatologic Reactions and HLA-B\*1502 Allele. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · Diagnostic and laboratory test selection and interpretation · NPCB 01 Assess · Adult · PMHNP-27

Answer: C. She may refuse treatment after an informed decision, so her choice stands.

The rule gives a patient, or her representative as allowed under state law, the right to make informed decisions about her care. That includes being informed of her health status, being involved in care planning, and being able to request or refuse treatment. She has capacity and has decided. Her age doesn't hand the decision to her daughter.

Why the other choices don't fit

• A. Age doesn't transfer decision-making. A representative's role depends on state law, not on a family member's preference.
• B. Clinical opinion doesn't override an informed refusal by a patient with capacity.
• D. The right to refuse treatment isn't limited to medications.

Takeaway: A patient with capacity can refuse treatment, including a strongly recommended one.

Source: 42 CFR 482.13: Hospital patients' rights, paragraph (b)(2), informed decisions and treatment refusal. Checked September 22, 2026.

Study tags: ANCC V. Ethics, Legal Principles, and Cultural Care · Patient's Bill of Rights (informed consent, treatment options) · NPCB 04 Evaluate · Older adult · PMHNP-28

Answer: C. Acute dystonia

The haloperidol label describes dystonia as prolonged abnormal muscle contractions in the first few days of treatment, including neck spasm that can progress to throat tightness and trouble swallowing or breathing. It is more common with high-potency, higher-dose first-generation antipsychotics and in males and younger patients, which fits him exactly. New swallowing difficulty with throat or neck dystonia needs immediate medical assessment because the airway may be involved.

Why the other choices don't fit

• A. Tardive dyskinesia is generally associated with cumulative exposure, although brief exposure does not make it impossible. Sudden sustained neck contraction and dysphagia in the first days fit the label's description of acute dystonia.
• B. The focal sustained contraction, absence of fever and normal vital signs favor acute dystonia over the NMS cluster described in the label. The vignette does not describe the characteristic combination of hyperpyrexia, muscle rigidity, altered mental status and autonomic instability.
• D. The newly introduced drug and sustained neck contraction fit acute dystonia better than serotonin syndrome. No serotonergic exposure is described in the vignette.

Takeaway: Young male, high-potency first-generation antipsychotic, first few days, sustained contraction: think acute dystonia.

Sources: DailyMed: Haloperidol oral solution prescribing information, Adverse Reactions: Dystonia; Warnings: Tardive Dyskinesia and Neuroleptic Malignant Syndrome; Prozac (fluoxetine) prescribing information, Lilly, section 5.2, serotonin syndrome. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Advanced psychopharmacology (EPS) · NPCB 02 Diagnose · Adolescent · PMHNP-29

Answer: B. Start with nonphysical de-escalation and other less restrictive steps.

Under the federal hospital patients' rights rule, restraint or seclusion may be used only to ensure the immediate physical safety of the patient, staff, or others, and only after less restrictive interventions have been found ineffective. It must be the least restrictive option that works. Staff training explicitly includes nonphysical intervention skills.

Why the other choices don't fit

• A. Seclusion is for violent or self-destructive behavior that threatens immediate physical safety. Pacing and yelling haven't reached that point.
• C. Without an immediate threat to physical safety, restraint isn't justified under the rule at all, whatever the paperwork.
• D. The rule prohibits standing or as-needed (PRN) orders for restraint or seclusion.

Takeaway: When there is no immediate physical danger, use nonphysical de-escalation and less restrictive measures. Restraint or seclusion cannot be ordered PRN.

Source: 42 CFR 482.13: Hospital patients' rights, paragraphs (e)(1)–(3), (e)(6) and (f)(2)(ii)–(iii). Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Psychiatric emergency management · NPCB 03 Plan · Adolescent · PMHNP-30

Answer: D. Parent training in behavior management, before medication is tried

For children with ADHD younger than 6, the CDC summary of AAP recommendations names parent training in behavior management as the first line of treatment, before medication. CDC notes that it works as well as medication in young children, that young children have more side effects from ADHD medications, and that long-term medication effects in this age group aren't well studied.

Why the other choices don't fit

• A. That reverses the recommended order for a child under 6.
• B. CDC calls behavior therapy an important first step now, not something to postpone.
• C. CDC identifies parent training in behavior management as the most effective behavior therapy for this age.

Takeaway: Under 6: parent training in behavior management first. For children 6 and older: medication plus behavior therapy.

Source: CDC: Treatment of ADHD, Treatment recommendations; By Age Group; Behavior therapy. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · Evidence-based practice (treatment selection) · NPCB 03 Plan · Infant and child · PMHNP-31

Answer: A. "You see yourself as a lighter drinker than your friends. What do you make of your own risks?"

NIAAA's brief intervention model asks clinicians to express empathy, stay focused on the patient's own drinking and risks rather than friends' habits, avoid arguing when patients push back, and support autonomy by reminding them the decision is theirs. This response reflects his view without arguing and brings the focus back to his own risks, leaving the decision with him.

Why the other choices don't fit

• B. Arguing with pushback is exactly what NIAAA advises against.
• C. NIAAA advises keeping the line of communication open, since change can take several visits.
• D. That abandons the focus on his own drinking and risks.

Takeaway: Roll with resistance: reflect, don't argue, affirm autonomy, and refocus on the patient's own risks.

Source: NIAAA: Conduct a Brief Intervention—Build Motivation and a Plan for Change, Seven-step model, especially steps 2–5. Checked September 22, 2026.

Study tags: ANCC IV. Psychotherapy and Related Theories · Psychotherapy principles (motivational interviewing) · NPCB 01 Assess · Adult · PMHNP-32

Answer: A. Bupropion is contraindicated because of her prior bulimia nervosa.

The bupropion XL label lists a current or prior diagnosis of bulimia or anorexia nervosa as a contraindication because of a higher seizure incidence. The word that matters is "prior." Remission doesn't remove it. For context, fluoxetine carries FDA indications for both major depressive disorder and bulimia nervosa.

Why the other choices don't fit

• B. The contraindication covers a prior diagnosis, not just active illness.
• C. Taking it with food doesn't change a seizure-risk contraindication.
• D. The label names both eating disorders.

Takeaway: Bupropion: no to seizure disorders and to current or prior bulimia or anorexia nervosa.

Sources: DailyMed: Bupropion hydrochloride extended-release tablets (XL), Camber, Section 4, Contraindications; Prozac (fluoxetine) prescribing information, Lilly, section 1, major depressive disorder and bulimia nervosa indications. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Advanced pharmacology (contraindications) · NPCB 01 Assess · Adult · PMHNP-33

Answer: C. If eligible, he may take up to 12 workweeks of unpaid, job-protected leave.

The FMLA gives eligible employees of covered employers up to 12 workweeks of job-protected leave in a 12-month period, including to care for a child with a serious mental or physical health condition. Eligibility means at least 12 months with the employer, 1,250 hours worked in the prior 12 months, and at least 50 employees within 75 miles. The FMLA itself does not guarantee pay; it may run concurrently with employer-provided paid leave, and it can be taken intermittently when medically necessary.

Why the other choices don't fit

• A. The FMLA itself guarantees eligible leave and job protection, not pay. Employer-provided paid leave may run at the same time.
• B. Caring for a child with a serious health condition is one of the covered reasons.
• D. DOL materials expressly include serious mental health conditions.

Takeaway: FMLA: up to 12 unpaid, job-protected workweeks, including care for a child's serious mental health condition.

Sources: U.S. Department of Labor: Fact Sheet 28O—Mental Health Conditions and the FMLA, About the FMLA; qualifying serious mental health conditions; care for a child; 29 CFR 825.202: Intermittent leave or reduced leave schedule, (a)–(b), especially (b)(1)–(2). Checked September 22, 2026.

Study tags: ANCC V. Ethics, Legal Principles, and Cultural Care · Patient advocacy (FMLA) · NPCB 03 Plan · Infant and child · PMHNP-34

Answer: B. Close monitoring early and after dose changes, with family watching daily

Fluoxetine is FDA-approved for major depressive disorder in pediatric patients 8 to 18, and it carries the antidepressant boxed warning for suicidal thinking and behavior in children, adolescents, and young adults. The label calls for close observation for clinical worsening, suicidality, and unusual behavior changes, especially in the first few months and at dose changes. It asks families to observe daily and report changes. It also recommends periodic height and weight checks and monitoring for mania in pediatric patients.

Why the other choices don't fit

• A. FDA approval and the boxed warning go together. Approval doesn't waive monitoring.
• C. The label doesn't call for routine drug levels.
• D. The label puts the burden on close observation by clinicians and family, not on self-report alone.

Takeaway: Antidepressants in youth: close monitoring early and at dose changes, and enlist the family.

Source: Prozac (fluoxetine) prescribing information, Lilly, Boxed Warning; sections 5.1 and 8.4. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · Psychopharmacotherapeutic management (monitoring) · NPCB 04 Evaluate · Adolescent · PMHNP-35

Answer: D. Advise him not to drink: he's under 21, and alcohol can worsen his condition.

NIAAA lists groups who should be advised not to drink at all. They include people younger than the legal drinking age of 21, people with a medical condition caused or worsened by drinking (bipolar disorder is one example given), and people taking certain medications. He checks more than one box.

Why the other choices don't fit

• A. A population drinking limit does not establish safety for this patient. NIAAA advises abstinence in the circumstances described here.
• B. Food timing doesn't change the reasons NIAAA gives for advising him not to drink.
• C. His question is a natural opening for exactly this health conversation.

Takeaway: NIAAA advises no alcohol for anyone under 21, for conditions alcohol worsens (bipolar disorder included), and with certain medications.

Source: NIAAA: Conduct a Brief Intervention—Build Motivation and a Plan for Change, Seven-step model, especially steps 2–5. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Health promotion and disease prevention · NPCB 03 Plan · Adolescent · PMHNP-36

Answer: D. SSRI-associated hyponatremia, often from SIADH

The fluoxetine label warns that SSRIs can cause hyponatremia, often through the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Older adults and people taking diuretics are at greater risk. Her symptoms (headache, confusion, unsteadiness leading to a fall) are the ones the label lists. The label says to consider stopping fluoxetine when hyponatremia is symptomatic and to start appropriate medical treatment. With new confusion and a fall, she needs urgent medical evaluation.

Why the other choices don't fit

• A. A measured sodium of 121 mEq/L with new symptoms points to a medical cause that needs attention first.
• B. The stem establishes symptomatic hyponatremia and does not establish the autonomic and neuromuscular syndrome described in the serotonin-syndrome warning. Taking an SSRI alone does not establish serotonin syndrome.
• C. Symptomatic hyponatremia can progress to seizures and worse. It isn't something to wait out.

Takeaway: Older adult plus diuretic plus new SSRI plus confusion: check the sodium.

Source: Prozac (fluoxetine) prescribing information, Lilly, sections 5.2, 5.9 and 8.5. Checked September 22, 2026.

Study tags: ANCC I. Scientific Foundation · Advanced pathophysiology · NPCB 02 Diagnose · Older adult · PMHNP-37

Answer: A. Write a safety plan with coping steps and contacts, and plan how to secure the pills.

NIMH separates a safety plan from a safety contract. The plan names coping strategies and the people or services the patient will reach out to. It also includes means restriction, because limiting access to dangerous objects saves lives. Pills at home make that conversation essential.

Why the other choices don't fit

• B. NIMH states that asking a patient to contract for safety is not effective and may be dangerous.
• C. Crisis numbers belong in the plan, but on their own they leave out coping steps, supports, and the pills.
• D. Skipping means counseling leaves access to potentially lethal medication unaddressed.

Takeaway: Safety plan, not safety contract, and always ask how lethal means will be secured.

Source: NIMH ASQ Toolkit: Adult Outpatient Brief Suicide Safety Assessment, PDF p. 2; step 3, safety plan and means safety. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Risk assessment (safety planning) · NPCB 03 Plan · Adult · PMHNP-38

Answer: C. Combining it with citalopram raises the risk of serotonin syndrome.

Citalopram's label lists St. John's wort among the serotonergic products that increase the risk of serotonin syndrome when combined with an SSRI. It asks clinicians to monitor for it and asks patients to tell their provider about herbal supplements. That's why supplements belong in every medication review.

Why the other choices don't fit

• A. "Natural" doesn't mean free of interactions, and the label names this one.
• B. Nothing in the labeling supports that, and citalopram's dose limits still apply.
• D. That misses the serotonin syndrome risk the label identifies.

Takeaway: St. John's wort plus an SSRI means serotonin syndrome risk. Always ask about supplements.

Source: Celexa (citalopram) prescribing information, AbbVie, sections 5.3 and 7; Medication Guide. Checked September 22, 2026.

Study tags: ANCC III. Diagnosis and Treatment · Complementary and alternative treatments · NPCB 01 Assess · Adult · PMHNP-39

Answer: B. Keep salt and fluids steady, avoid dehydration, and ask before taking ibuprofen.

The lithium label asks patients to keep a normal diet that includes salt and to drink enough fluid, and it warns that sweating, diarrhea, and fever reduce tolerance. It also names NSAIDs among drugs that raise lithium levels. The counseling section adds that patients shouldn't change their own dose, shouldn't double a missed dose, and should report toxicity signs such as diarrhea, vomiting, tremor, lack of coordination, and drowsiness.

Why the other choices don't fit

• A. Sodium loss reduces lithium clearance and raises the level. The label asks for a normal diet that includes salt.
• C. The label tells patients not to adjust the dose without their prescriber.
• D. The label specifically says not to double a missed dose.

Takeaway: Lithium teaching: steady salt and fluids, no DIY dosing, ask before NSAIDs, and know the toxicity signs.

Source: DailyMed: Lithium carbonate capsules, Glenmark, sections 5.1, 5.3, 7.1 and 17; Medication Guide. Checked September 22, 2026.

Study tags: ANCC II. Advanced Practice Skills · Psychoeducation (topic selection) · NPCB 03 Plan · Adult · PMHNP-40